ANTI-PD-L1 IMMUNOTOXIN FOR USE IN THERAPY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15563324

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to a combination of an anti-PD-L1 (Programmed Cell Death 1 Ligand 1) with an ‘immunotoxin’ for use in a method for treating a tumor in a patient. Experimental results are provided for a combination of an anti POL 1 antibody with the radioisotope Indium 111.

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS3 RUE MICHEL ANGE PARIS F-75016
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)75013 PARIS
UNIVERSITE D'AIX-MARSEILLE58 BD CHARLES LIVON MARSEILLE 13007
INSTITUT JEAN PAOLI & IRENE CALMETTES232 BOULEVARD DE SAINTE MARGUERITE MARSEILLE 13009

International Classification(s)

loading....
  • 2016 Application Filing Year
  • A61K Class
  • 19101 Applications Filed
  • 13019 Patents Issued To-Date
  • 68.16 % Issued To-Date
Click to zoom InYear of Issuance% of Matters IssuedCumulative IssuancesYearly Issuances20162017201820192020202120222023202420250255075100

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
OLIVE, Daniel Marseille, FR 52 375

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 4 Citation Count
  • A61K Class
  • 50.93 % this patent is cited more than
  • 7 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges92918022655157761477225301 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 100100 +050010001500200025003000350040004500500055006000650070007500800085009000950010000

Forward Cite Landscape

Load Citation